Hikma Pharmaceuticals PLC
1836.00
22-August-25 08:29:55
15 minutes delayed
Stocks
+20.00
+1.10%
Today's range
1815.00 - 1854.00
ISIN
N/A
Source
Cboe
-
U.S. FTC approves Hikma deal for Custopharm with conditions
19 Apr 2022 11:04:52 By NASDAQ US Markets
-
Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down
24 Feb 2022 00:43:25 By NASDAQ US Markets
-
Hikma To Acquire Teligent's Canadian Assets - Quick Facts
17 Jan 2022 00:32:15 By NASDAQ US Markets
-
Hikma Pharma Launches Outsourced Sterile Compounding Business - Quick Facts
09 Jan 2022 23:48:45 By NASDAQ US Markets